Commonwealth legislation

Therapeutic Goods Act 1989 - Determination under subsection 19A(3) (26/08/1997)

RepealedCTH

This Act has been repealed and is no longer in force. It is retained for historical reference.

Jurisdiction

Commonwealth

Collection

legislative instrument

Plain English Summary

1/10 complexity

This determination gives the Health Secretary emergency powers to fast-track approval for a specific yellow fever vaccine from France.

Normally, vaccines must go through a lengthy registration process before they can be used in Australia. However, the Therapeutic Goods Act allows the Secretary to approve unregistered medicines urgently in emergencies (such as disease outbreaks).

What this determination does:

Specifies France as an approved source country for emergency vaccine supplies
Identifies the exact product: Stamaril® Yellow Fever Vaccine
Names the specific manufacturer: Pasteur Mérieux Sérums and Vaccins

This creates a legal pathway for the Secretary to quickly authorise importation and supply of this specific French-made vaccine during urgent situations without waiting for full registration.

JSON API Health / NDIS / medicines

Deep dive

Want the full deep dive?

Zoe can write the in-depth analysis on top of the summary above: how it works, who it affects and what each part actually does.

Current sections

Direct links to the current provisions in Therapeutic Goods Act 1989 - Determination under subsection 19A(3) (26/08/1997).

Therapeutic Goods Act 1989 - Determination under subsection 19A(3) (26/08/1997)

meta-content-style-type: text/css meta-content-type: application/xhtml+xml; charset=utf-8 meta-generator: Aspose.Words for .NET 20.2 title: COMMONWEALTH OF AUSTRALIA

?xml version="1.0" encoding="utf-8" standalone="no"?>

COMMONWEALTH OF AUSTRALIA

THERAPEUTIC GOODS ACT 1989

SUBSECTION 19A(3) DETERMINATION

Pursuant to my powers under subsection 19A(3) of the Therapeutic Goods Act 1989, I, ANDREW PODGER, Secretary to the Department of Health and Family Services, specify France as the foreign country for the purposes of the exercise of my powers under subsection 19A(1) of the said Act in relation to Stamaril® Yellow Fever Vaccine manufactured by Pasteur Mérieux Sérums and Vaccins in France.

Dated this twenty sixth day of August 1997

ANDREW PODGER

Secretary

Department of Health and Family Services

Source text

Sourced from the Federal Register of Legislation (legislation.gov.au), CC BY 4.0.